InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
-6.3%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Hoyt Casey, Chief Executive Officer. Officer active across 1 company, notably Viemed Healthcare, INC.. Cumulatively, 20 filings have been logged. History available since 11 May 2021. The latest transaction was disclosed on 22 March 2024 (Don). Regulator: SEC (Form 4). All data is openly available.
Declarations20 total
49,597 sharesCommon SharesSEC:0001781871-26-000004
49,597 sharesCommon SharesSEC:0001781871-26-000004:0
39,796 sharesCommon SharesSEC:0001729149-25-000040:0
28,228 sharesCommon SharesSEC:0001729149-25-000029:0
40,068 sharesCommon SharesSEC:0001729149-25-000018:0
4,835 sharesCommon SharesSEC:0001729149-24-000139:0
26,000 shares0Common SharesSEC:0001729149-24-000085:0
8,568 shares@ US$7.6240.1% of flowCommon SharesSEC:0001729149-24-000058:0
13,189 shares@ US$7.3959.9% of flowCommon SharesSEC:0001729149-24-000055:0
28,228 sharesCommon SharesSEC:0001729149-24-000027:0
10,017 sharesCommon SharesSEC:0001729149-24-000009:0
2,010,943 shares0Common SharesSEC:0001729149-23-000118:0
4,620 sharesCommon SharesSEC:0001729149-23-000081:0
14,114 sharesCommon SharesSEC:0001729149-23-000028:0
14,114 sharesCommon SharesSEC:0001729149-23-000015:0
5,684 sharesCommon SharesSEC:0001729149-22-000053:0
10,000 shares0Common SharesSEC:0001729149-21-000097:0
10,000 shares0Common SharesSEC:0001729149-21-000097
59,702 sharesCommon SharesSEC:0001729149-21-000093
59,702 sharesCommon SharesSEC:0001729149-21-000093:0
20 of 20 declarations
About Hoyt Casey
Casey Hoyt serves as Chief Executive Officer of Viemed Healthcare, Inc. He leads the strategic operations of the company, focusing on growth and innovation. Casey has extensive experience in the sector, enabling him to effectively guide teams toward achieving organizational goals. His leadership is essential for the future development of Viemed.
